The study of diabetes prevalance in cancer cases

Objective & Hypothesis:Aim: Although there are a lot of studies that show the relationship between cancer and diabetes, some of these are contradictory.

📊

Key Findings & Data:Methods: With this purpose, we retrospectively searchedthe prevalance of diabetes in 1025 histopathologically verified carcinoma cases that came to our Department of Radiation Oncology and outpatient clinic of Medical Oncology at Dr.

💡

Conclusion & Impact:The prevalance of diabetes in colorectal cancers was significantly higher, when compared with other groups (p

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Aim: Although there are a lot of studies that show the relationship between cancer and diabetes, some of these are contradictory. In our study, we aimed to research the prevalance of diabetes in cancer patients and the relationship of this with different cancer types. Methods: With this purpose, we retrospectively searchedthe prevalance of diabetes in 1025 histopathologically verified carcinoma cases that came to our Department of Radiation Oncology and outpatient clinic of Medical Oncology at Dr. Lütfi Kırdar Kartal Research and Training Hospital. Before the initiation of chemo or radiotherapy; cases that had been diagnosed earlier as diabetic and were currently under antidiabetic treatment or whose fasting blood glucose levels were >126 mg/dl; were regarded as diabetic. In cases over 40 years of age we compared the prevalance of diabetes in various cancer types. Results: As we evaluate the cases for pathological diagnosis and localization; 297 (29%) were pulmonary cancers, 163 (15,9%) were breast cancers, 64 (6,2%) were colorectal cancers, 48 (4,7%) were stomach cancers, 69 (6,7 %) were lymphomas and 384 were other types of cancers. The prevalance of diabetes in certain cancer cases were found as follows: 7,7% in pulmonary cancers, 4,9% in breast cancers, 15,6% in colorectal cancers and none in stomach cancers. The prevalance of diabetes in colorectal cancers was significantly higher, when compared with other groups (p

Özet

Amaç: Kanser ve diabet ilişkisini gösteren birçok araştırma yapılmış olmasına rağmen, çelişen çalışmalar da vardır. Biz de bu çalışmada, kanser vakalarmdaki diabet sıklığını vè bu sıklığın farklı kanser türleriyle ilişkisini araştırmayı amaçladık. Metodlar: Bu amaçla, 2000-2001 yıllarında Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi Radyasyon Onkolojisi ve Tıbbi Onkoloji polikliniklerine başvuran ve histopatolojik kesin tanısı konulan 1025 vakada retrospektif olarak diabet sıklığını araştırdık. Kemoterapi ve radyoterapi öncesi dönemde, açlık kan şekeri >126 mg/dl olan veya daha önce diabet tanısı konulup antidiabetik tedavi altında olan vakalar diabetik olarak değerlendirildi. 40 yaş üzerindeki vakalarda, farklı kanser türlerinde diabet sıklığı karşılaştırıldı. Sonuçlar: Çalışmaya alınan vakaları patolojik tanı ve lokalizasyon açısından değerlendirdiğimizde, vakaların 297'si (% 29) akciğer kanseri, 163'ü (%15,9) meme kanseri, 64'ü (%6,2) kolorektal kanser, 48'i (%4,7) mide kanseri, 69'u (%6,7) lenfoma ve 384'ü diğer kanserler olarak tanı konulmuştu, diabet sıklığı akciğer kanseri vakalarında %7,7, meme kanserlerinde %4,9, kolorektal kanserlerde %15,6 olarak bulunmuş, mide kanserlerinde ise hiç diabetik vakaya rastlanmamıştır. Kolorektal kanser vakalarında diabet sıklığı diğer gruplara göre anlamlı olarak yüksekti (p

🔖

Cite This Article

SARGIN, H., YAYLA, A., SALEPÇİL, T., ÖZIŞIK, M., ÇAKIN, I., ALTUNTAŞ, Y., SARGIN, M., MAYADAĞLI, A. (2022). The study of diabetes prevalance in cancer cases. Endokrinolojide Yönelişler, Cilt: 11 - Sayı: 4, 160–164. https://ajindex.com/articles/500945

References (6)

Bloomgarden Z.T. Glucose tolerance, diabetes and cancer, glycemic control, monitoring, and related topics: American Diabetes Associati¬on 60th Scientific Sessions, 2000. Diabetes Care 24:779-784, 2001
Kath R, Schiel R, Muller U.A, Hoffken K. Malignancies in patients with insulin-treated diabetes mellitus: J. Cancer Res. Clin. Oncol. 2000 jul; 126(7):4l2-7
Le Marçhand L, Wilkens L.R, Kolonel L.N, Hankin J.H, Lyu L.C. Asso¬ciations of sedentary lifestyle, obesity, smoking, alcohol use, and di¬abetes with the risk of colorectal cancer: Cancer Res. 1997 nov. 1;57 (21):4787-94
Kim Y.I. Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link? Nutr. Rev. 1998 sep;56(9):275-9
Strickler H.D, Wylie-Rosett J, Rohan T, Hoover D.R, Smoller S, Burk R.D, Yu H. The relation of type 2 diabetes and cancer: Diabetes Tech-nol. Ther. 2001 summer;3(2):263-74
Giovanucci E.Insulin, insulin-like growth factors and colon cancer:a review of the evidence. J. Nutr. 2001 nov;13Kll Suppl.):3109S-20S. Kono S, 7. Honjo S, Todoroki I, Nishiwaki M, Hamada H, Nishikawa H, Koga H, Ogawa S, Nakagawa K. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan): Cancer Causes Cont¬rol 1998 aug;9(4):44l-6 8. Will J.C, Galuska D.A, Vinikor F, Calle E.E. Colorectal cancer: another complication of diabetes mellitus?: Am. J. Epidemiol. 1998 may 1; !47(9):8l6-25.